A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
Clinical trial NCT03568500 · COMPLETED
Trial details
- NCT number
- NCT03568500
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2019-05-21
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.